These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15498104)

  • 1. The Treatment of Bruxısm Assocıated With Fluoxetıne Usıng Olanzapine in 10-Year-Old Child: Case Report.
    Adıgüzel Akman Ö
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):440-442. PubMed ID: 38639444
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoxetine ameliorates mucopolysaccharidosis type IIIA.
    Capuozzo A; Montefusco S; Cacace V; Sofia M; Esposito A; Napolitano G; Nusco E; Polishchuk E; Pizzo MT; De Risi M; De Leonibus E; Sorrentino NC; Medina DL
    Mol Ther; 2022 Apr; 30(4):1432-1450. PubMed ID: 35121108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to Vicarious Social Defeat Stress and Western-Style Diets During Adolescence Leads to Physiological Dysregulation, Decreases in Reward Sensitivity, and Reduced Antidepressant Efficacy in Adulthood.
    Sial OK; Gnecco T; Cardona-Acosta AM; Vieregg E; Cardoso EA; Parise LF; Bolaños-Guzmán CA
    Front Neurosci; 2021; 15():701919. PubMed ID: 34408623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LGI1 governs neuritin-mediated resilience to chronic stress.
    Lee SH; Kim NS; Choi M; Ko SY; Wang SE; Jo HR; Seo JY; Kim YS; Kim HJ; Lee HY; Kim JH; Son H
    Neurobiol Stress; 2021 Nov; 15():100373. PubMed ID: 34401409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent fluoxetine treatment mediates a persistent anxiety-like outcome in female C57BL/6 mice that is ameliorated by fluoxetine re-exposure in adulthood.
    Flores-Ramirez FJ; Themann A; Sierra-Fonseca JA; Garcia-Carachure I; Castillo SA; Rodriguez M; Lira O; Preciado-Piña J; Warren BL; Robison AJ; Iñiguez SD
    Sci Rep; 2021 Apr; 11(1):7758. PubMed ID: 33833356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine exposure in adolescent and adult female mice decreases cocaine and sucrose preference later in life.
    Flores-Ramirez FJ; Garcia-Carachure I; Sanchez DO; Gonzalez C; Castillo SA; Arenivar MA; Themann A; Lira O; Rodriguez M; Preciado-Piña J; Iñiguez SD
    J Psychopharmacol; 2018 Oct; ():269881118805488. PubMed ID: 30334670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays.
    Perez-Costas E; Guidetti P; Melendez-Ferro M; Kelley JJ; Roberts RC
    J Neural Transm (Vienna); 2008 May; 115(5):745-53. PubMed ID: 18193153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
    Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
    Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight loss dynamics during combined fluoxetine and olanzapine treatment.
    Perrone JA; Chabla JM; Hallas BH; Horowitz JM; Torres G
    BMC Pharmacol; 2004 Oct; 4():27. PubMed ID: 15498104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
    Andersen SW; Clemow DB; Corya SA
    J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain.
    Agostinho FR; Scaini G; Ferreira GK; Jeremias IC; Réus GZ; Rezin GT; Castro AA; Zugno AI; Quevedo J; Streck EL
    Brain Res Bull; 2009 Dec; 80(6):337-40. PubMed ID: 19748553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility.
    Dodd S; Berk M
    Expert Rev Neurother; 2008 Sep; 8(9):1299-306. PubMed ID: 18759541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions.
    Marx CE; Shampine LJ; Khisti RT; Trost WT; Bradford DW; Grobin AC; Massing MW; Madison RD; Butterfield MI; Lieberman JA; Morrow AL
    Pharmacol Biochem Behav; 2006 Aug; 84(4):609-17. PubMed ID: 16996120
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.